Third set of draft test methods for Stage 2 released; McKesson to acquire MedVenture;

> The Office of the National Coordinator for Health IT has released the third set of draft test methods for the 2014 edition of Meaningful Use certification standards. All test methods are subject to two weeks of public review and comment. Test methods included in the third "wave" include clinical decision support, image results and clinical information reconciliation. Website

> McKesson has agreed to purchase MedVenture, a provider of population and risk management tools. The deal will augment McKesson's ability to help providers as they move towards clinical integration and risk-bearing programs, such as accountable care organizations. Announcement

> Oct. 3 is the last day for eligible professionals to begin the 90-day reporting period for the Meaningful Use incentive program for calendar year 2012. It's also the last year for eligible professionals to begin participating in the incentive program and get the full incentive amount of $44,000 per eligible professional. Website

And Finally... That's it: I'm switching to oatmeal. Article

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.